Pharmaceutial and Medical Device Law, published by the ABA Health Law Section and Bloomberg BNA, provides readers with an overview of key legal and regulatory issues that impact the development and marketing activities of pharmaceutical and medical device companies.

Carol Poindexter, Paul Sumilas and Vijay Rao have contributed to Chapter 8 (Federal Sentencing Guidelines and Compliance Measures), which covers topics such as

  • How to structure and manage compliance programs to meet government regulator expectations.
  • Strategies for managing investigations and navigating disclosure issues.
  • Potential individual liability for the board of directors and senior management.
  • Standards and best practices for compliance as set of forth in industry guidance.


Practice area:

Recent publications

US merger enforcement is… down? Lessons from the FY2021 HSR annual report

Publication

US Supreme Court clarifies scope of liability for omissions under Rule 10b-5(b)

The US Supreme Court has ruled that a “pure omission” under Item 303 of Securities and Exchange Commission Regulation S–K cannot give rise to a private action for securities fraud under Section 10(b) and Rule 10b-5(b) of the Securities Exchange Act of 1934.

United States | April 18, 2024

Regulation and investigations
insurance

Publication

What M&A trends will transform the 2024 insurance landscape?

It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.

Global | April 18, 2024

Insurance

Publication

The robots are coming … is insurance ready for AI?

The insurance industry is founded on predicting, as accurately as possible, whether or not a risk will materialise in a fast-moving competitive environment.

Global | April 18, 2024

Insurance
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now